ArticleCancers2022

Early On-Treatment Prediction of the Mechanisms of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors.

Yu-Ra Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.